This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Michael J. Goldstein, PhD; Eliot H. Rodnick, PhD; Jerome R. Evans, PhD; Philip R. A. May, MD; Mark R. Steinberg, MA

Arch Gen Psychiatry. 1978;35(10):1169-1177.

Abstract
• After a brief inpatient hospitalization, 104 acute, young schizophrenics, stratified by premorbid adjustment, were randomly assigned to one of four aftercare conditions for a six-week controlled trial. Conditions involved one of two dose levels of fluphenazine enanthate (1 ml or 0.25 ml) and presence or absence of crisis-oriented family therapy.

Relapses during the six-week period and at six-month follow--up were least in patients who received both high-dose and family therapy (0%) and greatest (48%) in the low-dose-no therapy group. Brief Psychiatric Rating Scale symptom ratings disclosed a significant family therapy effect at six weeks that was sustained at six months only for therapy patients originally receiving the high drug dose. Numerous interactions were found between premorbid adjustment status and response to the two treatment conditions.

Author Affiliations
From the Department of Psychology, University of California, Los Angeles.

Footnotes
Accepted for publication April 10, 1978.

Reprint requests to Department of Psychology, University of California, Los Angeles, CA 90024 (Dr Goldstein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Minimal-medication approaches to treating schizophrenia
Calton and Spandler
Adv. Psychiatr. Treat. 2009;15:209-217.
ABSTRACT | FULL TEXT  

Psychoeducation: A Basic Psychotherapeutic Intervention for Patients With Schizophrenia and Their Families
Bauml et al.
Schizophr Bull 2006;32:S1-S9.
ABSTRACT | FULL TEXT  

Efficacy of Psychological Therapy in Schizophrenia: Conclusions From Meta-analyses
Pfammatter et al.
Schizophr Bull 2006;32:S64-S80.
ABSTRACT | FULL TEXT  

The Potential Impact of the Recovery Movement on Family Interventions for Schizophrenia: Opportunities and Obstacles
Glynn et al.
Schizophr Bull 2006;32:451-463.
ABSTRACT | FULL TEXT  

Meeting the mental and physical healthcare needs of carers
Cormac and Tihanyi
Adv. Psychiatr. Treat. 2006;12:162-172.
ABSTRACT | FULL TEXT  

Schizophrenia and Other Psychotic Disorders
Jibson et al.
Focus 2004;2:17-30.
ABSTRACT | FULL TEXT  

The Effect of Family Interventions on Relapse and Rehospitalization in Schizophrenia: A Meta-Analysis
Pitschel-Walz et al.
Focus 2004;2:78-94.
ABSTRACT | FULL TEXT  

Maintenance Medication for Schizophrenia: Strategies for Dose Reduction
Schooler
Focus 2004;2:175-186.
ABSTRACT | FULL TEXT  

Integration of Care: Integrated Treatment of Schizophrenia
Lenroot et al.
Psychiatr. Serv. 2003;54:1499-1507.
ABSTRACT | FULL TEXT  

A Randomized Study of Family-Focused Psychoeducation and Pharmacotherapy in the Outpatient Management of Bipolar Disorder
Miklowitz et al.
Arch Gen Psychiatry 2003;60:904-912.
ABSTRACT | FULL TEXT  

Predictors of Dissemination of Family Psychoeducation in Community Mental Health Centers in Maine and Illinois
McFarlane et al.
Psychiatr. Serv. 2001;52:935-942.
ABSTRACT | FULL TEXT  

Management of Negative Symptoms Among Patients With Schizophrenia Attending Multiple-Family Groups
Dyck et al.
Psychiatr. Serv. 2000;51:513-519.
ABSTRACT | FULL TEXT  

Individual Psychopathology and Marital Distress: Analyzing the Association and Implications for Therapy
Halford et al.
Behav Modif 1999;23:179-216.
ABSTRACT  

Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia: The Effects of Dose Reduction and Family Treatment
Schooler et al.
Arch Gen Psychiatry 1997;54:453-463.
ABSTRACT  

The Influence of Expressed Emotion, Family Dynamics, and Symptom Type on the Social Adjustment of Schizophrenic Young Adults
King and Dixon
Arch Gen Psychiatry 1996;53:1098-1104.
ABSTRACT  

Multiple-Family Groups and Psychoeducation in the Treatment of Schizophrenia
McFarlane et al.
Arch Gen Psychiatry 1995;52:679-687.
ABSTRACT  

Schizophrenia
Carpenter and Buchanan
NEJM 1994;330:681-690.
FULL TEXT  

Intermittent vs Maintenance Medication in Schizophrenia: Two-Year Results
Herz et al.
Arch Gen Psychiatry 1991;48:333-339.
ABSTRACT  

Family Interventions for Schizophrenia
Tarrier and Barrowclough
Behav Modif 1990;14:408-440.
ABSTRACT  

Process Analysis in Behavioral Family Therapy
Hahlweg et al.
Behav Modif 1990;14:441-456.
ABSTRACT  

Behavioral Family Treatment for Patients with Bipolar Affective Disorder
Miklowitz and Goldstein
Behav Modif 1990;14:457-489.
ABSTRACT  

Dose of Fluphenazine, Familial Expressed Emotion, and Outcome in Schizophrenia: Results of a Two-Year Controlled Study
Hogarty et al.
Arch Gen Psychiatry 1988;45:797-805.
ABSTRACT  

Differential Effect of Low and Conventional Doses of Fluphenazine on Schizophrenic Outpatients With Good or Poor Information-Processing Abilities
Asarnow et al.
Arch Gen Psychiatry 1988;45:822-826.
ABSTRACT  

Inpatient Family Intervention: A Randomized Clinical Trial: II. Results at Hospital Discharge
Haas et al.
Arch Gen Psychiatry 1988;45:217-224.
ABSTRACT  

Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini et al.
Arch Gen Psychiatry 1988;45:79-91.
ABSTRACT  

The Impact of Mental Illness on Families: Concepts and Priorities
GUBMAN and TESSLER
Journal of Family Issues 1987;8:226-245.
ABSTRACT  

Low- and Conventional-Dose Maintenance Therapy With Fluphenazine Decanoate: Two-Year Outcome
Marder et al.
Arch Gen Psychiatry 1987;44:518-521.
ABSTRACT  

Family Psychoeducation, Social Skills Training, and Maintenance Chemotherapy in the Aftercare Treatment of Schizophrenia: I. One-Year Effects of a Controlled Study on Relapse and Expressed Emotion
Hogarty et al.
Arch Gen Psychiatry 1986;43:633-642.
ABSTRACT  

Family Management in the Prevention of Morbidity of Schizophrenia: Clinical Outcome of a Two-Year Longitudinal Study
Falloon et al.
Arch Gen Psychiatry 1985;42:887-896.
ABSTRACT  

The Economic Costs of Schizophrenia: Implications for Public Policy
Andrews et al.
Arch Gen Psychiatry 1985;42:537-543.
ABSTRACT  

Costs and Benefits of Two Doses of Fluphenazine
Marder et al.
Arch Gen Psychiatry 1984;41:1025-1029.
ABSTRACT  

Reliability of Norepinephrine and Major Monoamine Metabolite Measurements in CSF of Schizophrenic Patients
Linnoila et al.
Arch Gen Psychiatry 1983;40:1290-1294.
ABSTRACT  

Low-Dose Neuroleptic Treatment of Outpatient Schizophrenics: I. Preliminary Results for Relapse Rates
Kane et al.
Arch Gen Psychiatry 1983;40:893-896.
ABSTRACT  

Psychiatry
Freedman
JAMA 1979;241:1373-1375.
ABSTRACT